ClinicalTrials.Veeva

Menu

Study on the Occurrence of Head and Neck Cancers During Pregnancy (REFCORbirth)

C

Centre Francois Baclesse

Status

Suspended

Conditions

Pregnancy Related
Head and Neck Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT03738267
2018-A01220-55

Details and patient eligibility

About

Head and neck cancers that occurred during pregnancy

Enrollment

14 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 year old woman or over at the time of participation
  • PS 0 -2
  • Cancer diagnosed (biopsy date) from 01/01/2010 between the second week of pregnancy and the 12 months postpartum.
  • Primitive may concern the following sites:

oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, prevalent lymphadenopathy, nasal cavity, salivary glands, dental tumors, ear tumors, paragangliomas optic pathways, facial sinus / facial mass, nose, ear and other head and neck

  • All histologies (epithelial tumors, sarcomas, mucosal melanomas, embryonic tumors, undifferentiated tumors)
  • Patient receiving or having received a specific oncological treatment among surgery, radiotherapy, chemotherapy, hormone therapy.
  • All stages allowed: localized stages and metastatic stages immediately.
  • No opposition of the patient to participate in this study

Exclusion criteria

  • Any other neoplastic antecedent
  • Exclusion of metastases at the level of the VADS of another primitive than a cancer of the VADS
  • Exclusion of hematological tumors (lymphoma) and glial tumors
  • Person subject to a legal protection measure or unable to express their consent

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems